Emmaus Life Sciences, INC. (EMMA) — 8-K Filings
All 8-K filings from Emmaus Life Sciences, INC.. Browse 19 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (19)
-
Emmaus Life Sciences Files 8-K with Financial Results
— Mar 31, 2026 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on March 31, 2026, reporting its financial results and condition as of March 30, 2026. The filing includes a press relea - 8-K Filing — Dec 31, 2025
- 8-K Filing — Dec 22, 2025
-
Emmaus Life Sciences Files 8-K on Director/Officer Changes
— Dec 19, 2025 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on December 19, 2025, reporting on events as of December 15, 2025. The filing covers the departure of directors, electio - 8-K Filing — Nov 14, 2025
-
Emmaus Life Sciences Files 8-K on Financials
— Aug 14, 2025 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing includes financial statem -
Emmaus Life Sciences Files 8-K with Officer and Director Updates
— Jul 1, 2025 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on June 30, 2025, reporting changes in its board of directors and executive officers, as well as updates to compensatory -
Emmaus Life Sciences Files 8-K on Financials
— May 15, 2025 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statement -
Emmaus Life Sciences Changes Independent Auditor
— May 6, 2025 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on May 6, 2025, reporting a change in its certifying accountant. The company previously engaged WithumSmith+Brown, PC, b -
Emmaus Life Sciences Files 8-K on Financials
— Apr 14, 2025 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on April 14, 2025, reporting on its results of operations and financial condition. The filing also includes financial st -
Emmaus Life Sciences Files 8-K on Financials
— Nov 19, 2024 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on November 19, 2024, reporting on its results of operations and financial condition, as well as financial statements an -
Emmaus Life Sciences Board Changes and Officer Compensation
— Nov 6, 2024 Risk: medium
Emmaus Life Sciences, Inc. announced on November 4, 2024, a change in its board of directors. Specifically, Dr. Y. K. Kim has been appointed as a new director, -
Emmaus Life Sciences Appoints New Auditor
— Oct 25, 2024 Risk: medium
Emmaus Life Sciences, Inc. announced on October 22, 2024, that it has appointed a new independent registered public accounting firm, CohnReznick LLP, to audit i -
Emmaus Life Sciences Files 8-K on Officer/Director Changes
— Oct 4, 2024 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on October 4, 2024, reporting on events as of September 30, 2024. The filing covers the departure of directors or certai -
Emmaus Life Sciences Changes Auditors
— Sep 10, 2024 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on September 5, 2024, reporting changes in its certifying accountant. The company has dismissed its previous independent -
Emmaus Life Sciences Files 8-K on Director/Officer Changes
— Jul 17, 2024 Risk: medium
Emmaus Life Sciences, Inc. filed an 8-K on July 17, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compe -
Emmaus Life Sciences Files 8-K on Financials
— Jul 3, 2024 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on July 3, 2024, reporting on its results of operations and financial condition. The filing includes financial statement -
Emmaus Life Sciences Changes Fiscal Year End
— May 28, 2024 Risk: low
Emmaus Life Sciences, Inc. filed an 8-K on May 28, 2024, reporting a change in its fiscal year end to December 31st. This change is effective as of May 23, 2024 -
Emmaus Life Sciences Reports New Financial Obligations and Equity Sales
— Feb 26, 2024 Risk: medium
Emmaus Life Sciences, Inc. entered into a Material Definitive Agreement and created a Direct Financial Obligation on February 21, 2024. This filing also reports
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX